Nexium lawsuit plaintiffs continue to press claims over the drug’s alleged link to kidney failure and other renal complications in courts around the country. At least one new filing was recently recorded in New Jersey, while another plaintiff was given leave to move forward with design defect and failure-to-warn claims by the Louisiana federal court overseeing her case.
According to a complaint filed on March 30th in the U.S. District Court, District of New Jersey, Roni Jones began taking Nexium in 2013, per the warnings and directions included on its labeling. She continued using the medication through 2016. Jones asserts that her continued use of the proton pump inhibitor caused her to develop acute and chronic kidney disease, resulting in severe and permanent injuries, as well as pain, suffering, economic loss and emotional distress. (Case No. 2:17-cv-02098)
“Studies have shown the long term use of PPIs was independently associated with a 20% to 50% higher risk of CKD, after adjusting for several potential confounding variables, including demographics, socioeconomic status, clinical measurements, prevalent co-morbidities, and concomitant use of medications,” the Jones Complaint states. “Currently, the Nexium product labeling does not contain any warning regarding the increased risk of CKD.”
According to a report from RXInjuryHelp.com, Alice Donald also filed a Nexium lawsuit in the U.S. District Court, Eastern District of Louisiana, after she developed kidney failure allegedly related to her longer-term use of the medication. However, AstraZeneca had moved to have her case dismissed. (Case No. 16-17753)
In an Order issued on March 22nd, the Court upheld Donald’s claims of defect in construction or composition, design defect, and failure-to-warn were upheld, after the Court found that they were sufficiently pled. However, the Court did dismiss the lawsuit’s non-Louisiana Products Liability Act claims, after finding that the state statute is the exclusive remedy. Donald’s breach of express warranty claim was also dismissed after the Court determined that the complaint was void of any such allegation.
These two cases are among dozens of similar kidney injury lawsuits recently filed against the manufacturers of Nexium and other proton pump inhibitors. Bernstein Liebhard LLP is representing plaintiffs in a number of these cases, and our attorneys continue to offer free legal reviews to prospective claimants.
To learn more, please call (888) 994-5118 to discuss filing a Nexium lawsuit with a member of our legal team today.